ZANGO KATAF, JABA PDP COMMITTEES HOLD RECONCILIATION MEETING AHEAD OF 2027 ELECTIONS. (PHOTO).

Image
 Zango Kataf, Jaba PDP Committees Hold Reconciliation Meeting Ahead Of 2027 Elections The Peoples Democratic Party (PDP) Working Committees in Zango Kataf and Jaba Local Government Areas have held a strategic reconciliation meeting aimed at strengthening party unity and positioning the party for success in the 2027 general elections. The meeting, held on Friday, July 31, 2026, in Jaba Local Government Area, was jointly chaired by the PDP Chairmen of Jaba and Zango Kataf LGAs, Sabastine David Bijiri and Martins Markus Koyah. It brought together party executives, stakeholders, ward officials, elders, youth and women leaders, as well as members from both local government areas. Speaking at the meeting, the Zango Kataf PDP Chairman commended party leaders and members for supporting the zoning of the party’s House of Representatives ticket to Zango Kataf Local Government Area. He described the decision as a reflection of the party’s commitment to fairness, equity, inclusion, and mutual ...

GSK CEO TO RESIGN BY THE END OF THE YEAR. (PHOTO).


 GSK CEO to resign by the end of the year

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down on Dec. 31 after more than eight years at the helm of the London-based drugmaker.

Walmsley, 56, will be succeeded by Luke Miels, currently GSK’s chief commercial officer, the company announced Monday. During her tenure, Walmsley oversaw several strategic initiatives, including the spinoff of the consumer health business Haleon, but the company’s overall performance has underwhelmed investors. GSK shares rose 3.3% to 1,534.50 pence in early trading, making it the top gainer on the London Stock Exchange.

Despite these gains, GSK’s stock has fallen 11% since Walmsley took over on April 1, 2017. Analysts say the company has delivered on financial guidance but continues to experience slow growth. Derren Nathan, head of equity research at U.K.-based Hargreaves Lansdown, noted that while GSK has achieved progress, “the share price performance has been lackluster” and growth rates remain in the single digits.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.